Skip to main content

Table 1 Demographic and clinical features of Parkinson’ disease patients

From: Ceruloplasmin functional changes in Parkinson’s disease-cerebrospinal fluid

  Sex Age at examination [C] mg/ml Diag. Disease duration (months) Clinical subtype UPDRS I UPDRS II UPDRS III Hoen & Yahr MMSE
#1 M 65 0.38 PD 7 Tremble 0 4 4 1 30
#2 F 56 0.46 PD 10 Akinetic 1 9 29 1 29
#3 F 68 0.51 PD 8 Akinetic 2 3 14 2 28
#4 M 60 0.34 PD 10 Tremble 0 5 6 1.5 30
#5 M 70 0.39 PD 9 Tremble 0 3 5 1 30
#6 F 70 0.41 PD 12 Tremble 1 5 7 2 27
#7 F 73 0.46 PD 8 Tremble 3 9 19 1 29
#8 M 56 0.30 PD - Tremble 3 5 26 2 30
#9 F 66 0.60 PD 13 Tremble 0 8 17 1 30
#10 F 82 0.16 PD 9 Tremble 2 10 14 1 27
#11 M 80 0.47 PD - Akinetic 1 7 22 1.5 29
#12 F 56 0.19 PD + D >12 Akinetic 7 20 34 2.5 22
  5 M/7 F 66.5 ± 8.3 0.39 ± 0.13         
   m ± sd m ± sd         
  1. [C] mg/ml = CSF total protein concentration; UPDRS = Unified Parkinson’s Disease Rating Scale; m = mean; sd = standard deviation
  2. PD = Parkinson’s disease; D = dementia; Diag: confirmed diagnosis; MMSE: Mini Mental State Examination